GCG and diabetes mellitus: Units sold per person from 2014 to 2021 were 0.407 ± 0.661 to 0.507 ± 0.774 (Mean ± SD) in 2021, that means that < 50% of persons with diabetes had glucagon available, and probably even fewer persons were treated with glucagon for SH.